Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem CellsTissue DonorsGraft SurvivalAnemia, AplasticLeukemiaBone and BonesHematologic NeoplasmsTransplantation ChimeraHistocompatibility TestingBusulfanHistocompatibilityKidney TransplantationTreatment OutcomeBone Marrow PurgingLiver TransplantationTransplantationRecurrenceImmunosuppressive AgentsCombined Modality TherapyCyclophosphamideTime FactorsCytomegalovirus InfectionsRetrospective StudiesGraft RejectionHematopoiesisTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLHepatic Veno-Occlusive DiseaseLeukemia, Myeloid, AcutePeripheral Blood Stem Cell TransplantationCell DifferentiationImmunocompromised HostBone Marrow DiseasesSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionImmunosuppressionOpportunistic InfectionsAcute DiseaseHematologic DiseasesHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsRadiation ChimeraSurvival RateLymphocyte DepletionLeukocyte TransfusionTransplantation ImmunologyEmbryonic Stem CellsLymphoma, Non-HodgkinLeukemia, MyeloidFlow CytometryFollow-Up StudiesCyclosporineBone Marrow ExaminationHLA AntigensCell ProliferationAdult Stem CellsMultiple MyelomaT-LymphocytesLung TransplantationHematopoietic Stem Cell MobilizationColony-Forming Units AssayMyelodysplastic SyndromesCells, CulturedMesenchymal Stem Cell TransplantationNeoplasmsBone RemodelingAntineoplastic AgentsBone Marrow NeoplasmsDisease-Free SurvivalFatal OutcomeAntigens, CD34PrognosisGraft vs Host ReactionOrgan TransplantationChimeraGranulocyte Colony-Stimulating FactorCord Blood Stem Cell TransplantationAspergillosisGraft vs Leukemia EffectMelphalanBreast NeoplasmsMycosesSevere Combined ImmunodeficiencyProspective StudiesCytomegalovirusMice, Inbred BALB CTransplants